Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Nano-X Imaging Ltd.NASDAQ: NNOX
Depreciation & Amortization · Q4 FY2025 · quarter ended Dec 2025
Depreciation & amortization declines year over year
Q4 FY2025 depreciation & amortization of $2.85M fell 3.0% year over year, behind the -0.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 3.8% from the prior quarter. Over 3 fiscal years it compounded at +0.5% a year.
Context
- Depreciation & amortization amounted to 89.8% of revenue in FY2025, down 14.2 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -3.0% toward the trailing-twelve-month pace of -0.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 11.7M USD
- Year-over-year change
- -0.3%
- 4-year CAGR
- +50.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.7M | -0.3% |
| FY2024 | 2024-12-31 | 11.73M | -0.7% |
| FY2023 | 2023-12-31 | 11.81M | +2.6% |
| FY2022 | 2022-12-31 | 11.51M | +402.3% |
| FY2021 | 2021-12-31 | 2.29M | — |
Depreciation & Amortization vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's LTM Dec 2025 depreciation & amortization of $11.7M is the 4th largest of the 11 companies compared; the peer median is $3.19M.
- Its year-over-year change of -0.3% is the 7th highest of 11, against a peer median of +11.5%.
- Depreciation & amortization amounts to 89.8% of revenue for NNOX, versus a peer median of 6.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $50.3M | +18.5% | +1.5% | 16.6% | |
| LTM Mar 2026 | $22.58M | +148.0% | +52.4% | 15.6% | |
| LTM Mar 2026 | $20.37M | -2.6% | -4.2% | 5.8% | |
| LTM Dec 2025 | $11.7M | -0.3% | +0.5% | 89.8% | |
| LTM Mar 2026 | $4.68M | +4.5% | +24.0% | 14.5% | |
| LTM Mar 2026 | $3.65M | +35.4% | +111.4% | 589.8% | |
| LTM Mar 2026 | $2.74M | +63.9% | -5.7% | 2.3% | |
| LTM Mar 2026 | $672K | +1192.3% | +30.5% | 7.0% | |
| LTM Mar 2026 | $589K | -20.5% | +16.3% | 1.3% | |
| LTM Mar 2026 | $499.37K | -27.3% | -29.2% | 2.6% | |
| LTM Mar 2026 | $103K | -90.0% | +10.5% | 0.2% | |
| Peer median (excluding NNOX) | $3.19M | +11.5% | +13.4% | 6.4% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| Deferred Income Tax | (116K) | (3.73M) | (377K) | (377K) | (1.98M) |
| Stock-Based Compensation | 18.81M | 18.62M | 6.84M | 7.26M | 4.19M |
| Change in Working Capital | 2.75M | (16.95M) | (7.48M) | (1.13M) | 2.77M |
| Accounts Receivables | (40K) | 74K | (507K) | (321K) | 107K |
| Inventory | 864K | 0 | 0 | (277K) | (325K) |
| Accounts Payables | 1.72M | 469K | (153K) | (1.32M) | 288K |
| Other Working Capital | 202K | (17.49M) | (6.82M) | 787K | 2.7M |
| Other Non-Cash Items | (2K) | 52.4M | 5.21M | (572K) | 17.54M |
| Operating Cash Flow | (38.07M) | (43.39M) | (44.78M) | (36.6M) | (40.79M) |
| Capital Expenditures | (23.16M) | (7.17M) | (3.3M) | (2.77M) | (4.21M) |
| Acquisitions (Net) | (2.86M) | 1.01M | 0 | 0 | 0 |
| Purchases of Investments | (90.3M) | (9.46M) | (373K) | (58.52M) | (15K) |
| Sales of Investments | 90.3M | 31.24M | 39.11M | 41.19M | 33.8M |
| Other Investing Activities | (90.3M) | (1.01M) | (373K) | 46K | (200K) |
| Investing Cash Flow | (116.32M) | 14.61M | 35.43M | (20.05M) | 29.37M |
| Debt Repayment | 3.8M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 3.58M | 949K | 27.14M | 37.83M | 21.37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.58M | 804K | 113K | 1.67M | 0 |
| Financing Cash Flow | 7.38M | 804K | 27.25M | 39.5M | 21.37M |
| Effect of Forex Changes | (10K) | (268K) | (60K) | 72K | (101K) |
| Net Change in Cash | (147.01M) | (28.24M) | 17.85M | (17.07M) | 9.85M |
| Free Cash Flow | (61.23M) | (50.56M) | (48.08M) | (39.37M) | (45M) |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.